<SEC-DOCUMENT>0001950047-25-006944.txt : 20250910
<SEC-HEADER>0001950047-25-006944.hdr.sgml : 20250910
<ACCEPTANCE-DATETIME>20250910163749
ACCESSION NUMBER:		0001950047-25-006944
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250910
DATE AS OF CHANGE:		20250910

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BeOne Medicines Ltd.
		CENTRAL INDEX KEY:			0001651308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				981209416
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-37686
		FILM NUMBER:		251306299

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		C/O BEONE MEDICINES I GMBH
		STREET 2:		AESCHENGRABEN 27, 21ST FLOOR
		CITY:			BASEL
		PROVINCE COUNTRY:   	V8
		ZIP:			4051
		BUSINESS PHONE:		41-616851900

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		C/O BEONE MEDICINES I GMBH
		STREET 2:		AESCHENGRABEN 27, 21ST FLOOR
		CITY:			BASEL
		PROVINCE COUNTRY:   	V8
		ZIP:			4051

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BeiGene, Ltd.
		DATE OF NAME CHANGE:	20150819

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lee Chan Henry
		CENTRAL INDEX KEY:			0001980648
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		55 CAMBRIDGE PARKWAY
		STREET 2:		SUITE 700W
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001980648</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001651308</issuerCik>
            <issuerName>BeOne Medicines Ltd.</issuerName>
            <secFileNumber>001-37686</secFileNumber>
            <issuerAddress>
                <ns2:street1>Aeschengraben 27, 21st Floor</ns2:street1>
                <ns2:city>Basel</ns2:city>
                <ns2:stateOrCountry>V8</ns2:stateOrCountry>
                <ns2:zipCode>4051</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>41-616851900</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>CHAN LEE</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>9010</noOfUnitsSold>
            <aggregateMarketValue>3163681.30</aggregateMarketValue>
            <noOfUnitsOutstanding>54564278</noOfUnitsOutstanding>
            <approxSaleDate>09/10/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <acquiredDate>09/10/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>8894</amountOfSecuritiesAcquired>
            <paymentDate>09/10/2025</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <securitiesToBeSold>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <acquiredDate>06/15/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Restricted Stock Units</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>116</amountOfSecuritiesAcquired>
            <paymentDate>06/15/2025</paymentDate>
            <natureOfPayment>N/A</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales for CHAN LEE</name>
                <address>
                    <ns2:street1>Aeschengraben 27, 21st Floor</ns2:street1>
                    <ns2:city>Basel</ns2:city>
                    <ns2:stateOrCountry>V8</ns2:stateOrCountry>
                    <ns2:zipCode>4051</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <saleDate>08/13/2025</saleDate>
            <amountOfSecuritiesSold>9342</amountOfSecuritiesSold>
            <grossProceeds>2805905.17</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>CHAN LEE</name>
                <address>
                    <ns2:street1>Aeschengraben 27, 21st Floor</ns2:street1>
                    <ns2:city>Basel</ns2:city>
                    <ns2:stateOrCountry>V8</ns2:stateOrCountry>
                    <ns2:zipCode>4051</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <saleDate>07/30/2025</saleDate>
            <amountOfSecuritiesSold>920</amountOfSecuritiesSold>
            <grossProceeds>280232.74</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>CHAN LEE</name>
                <address>
                    <ns2:street1>Aeschengraben 27, 21st Floor</ns2:street1>
                    <ns2:city>Basel</ns2:city>
                    <ns2:stateOrCountry>V8</ns2:stateOrCountry>
                    <ns2:zipCode>4051</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>ADS</securitiesClassTitle>
            <saleDate>06/16/2025</saleDate>
            <amountOfSecuritiesSold>422</amountOfSecuritiesSold>
            <grossProceeds>112463.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>09/10/2025</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>05/14/2025</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Chan Lee</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
